Obinutuzumab
Zanubrutinib
Update Venetoclax in CLL
Acalabrutinib
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Leukemia & Lymphoma Society
NCCN Guidelines for Patients for CLL
NCCN Guidelines for Patients